Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechSci Research | PRODUCT CODE: 1886405

Cover Image

PUBLISHER: TechSci Research | PRODUCT CODE: 1886405

Transcranial Magnetic Stimulation System Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Type, By Application, By Age Group, By Region and Competition, 2020-2030F

PUBLISHED:
PAGES: 185 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4500
PDF and Excel (Multi-User License)
USD 5500
PDF and Excel (Custom Research License)
USD 8000

Add to Cart

We offer 8 hour analyst time for an additional research. Please contact us for the details.

The Global Transcranial Magnetic Stimulation System Market, valued at USD 1.65 Billion in 2024, is projected to experience a CAGR of 6.93% to reach USD 2.47 Billion by 2030. Transcranial Magnetic Stimulation (TMS) systems are non-invasive medical devices that utilize magnetic fields to induce electrical currents in targeted brain regions for therapeutic modulation of neural activity. The global market for these systems is primarily driven by the escalating prevalence of neurological and psychiatric disorders, coupled with increasing awareness of non-invasive treatment options.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.65 Billion
Market Size 2030USD 2.47 Billion
CAGR 2025-20306.93%
Fastest Growing SegmentRepetitive Transcranial Magnetic Stimulation
Largest MarketNorth America

Key Market Drivers

The escalating prevalence of neurological and mental health conditions profoundly influences the global Transcranial Magnetic Stimulation System market by expanding the fundamental patient population requiring advanced therapeutic interventions. Widespread conditions like major depressive disorder, anxiety disorders, and obsessive-compulsive disorder necessitate effective treatment modalities beyond conventional pharmacotherapy. This growing disease burden directly translates into increased demand for non-invasive options such as TMS, particularly for individuals not adequately responding to medication or seeking alternative approaches. The sheer scale of these challenges underscores the urgent need for accessible and efficacious treatments.

Key Market Challenges

The high initial cost associated with Transcranial Magnetic Stimulation (TMS) devices and treatments represents a significant barrier to market expansion. Healthcare providers, particularly those in regions with developing healthcare infrastructure or constrained budgets, face considerable challenges in allocating capital for such advanced equipment. This financial impediment directly restricts the broad adoption of TMS technology, limiting its availability to a wider patient demographic and hindering market penetration. The cost factor extends beyond the purchase price to include installation, specialized facility modifications, and ongoing maintenance expenses.

Key Market Trends

The rise of specialized outpatient TMS clinics represents a critical trend, expanding access to advanced neurostimulation treatments beyond traditional hospital settings. These dedicated facilities streamline patient pathways, offering focused expertise and environments conducive to long-term care for conditions like major depressive disorder and obsessive-compulsive disorder. The expansion of these clinics is often driven by manufacturers, with companies actively supporting the establishment of new treatment centers.

Key Market Players

  • BrainsWay Ltd.
  • Magstim, Inc.
  • Nexstim Oyj
  • MagVenture A/S
  • eNeura Inc.
  • Koninklijke Philips N.V.
  • Labtician Ophthalmics, Inc.
  • Vision Care USA, Inc.

Report Scope:

In this report, the Global Transcranial Magnetic Stimulation System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Transcranial Magnetic Stimulation System Market, By Type:

  • Deep Transcranial Magnetic Stimulation
  • Repetitive Transcranial Magnetic Stimulation
  • Others

Transcranial Magnetic Stimulation System Market, By Application:

  • Alzheimer's Disease
  • Depression
  • Parkinson's Disease
  • Epilepsy
  • Others

Transcranial Magnetic Stimulation System Market, By Age Group:

  • Adults
  • Children

Transcranial Magnetic Stimulation System Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Transcranial Magnetic Stimulation System Market.

Available Customizations:

Global Transcranial Magnetic Stimulation System Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Product Code: 22432

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Transcranial Magnetic Stimulation System Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Deep Transcranial Magnetic Stimulation, Repetitive Transcranial Magnetic Stimulation, Others)
    • 5.2.2. By Application (Alzheimer's Disease, Depression, Parkinson's Disease, Epilepsy, Others)
    • 5.2.3. By Age Group (Adults, Children)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Transcranial Magnetic Stimulation System Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Age Group
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Transcranial Magnetic Stimulation System Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Age Group
    • 6.3.2. Canada Transcranial Magnetic Stimulation System Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Age Group
    • 6.3.3. Mexico Transcranial Magnetic Stimulation System Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Age Group

7. Europe Transcranial Magnetic Stimulation System Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Age Group
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Transcranial Magnetic Stimulation System Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Age Group
    • 7.3.2. France Transcranial Magnetic Stimulation System Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Age Group
    • 7.3.3. United Kingdom Transcranial Magnetic Stimulation System Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Age Group
    • 7.3.4. Italy Transcranial Magnetic Stimulation System Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Age Group
    • 7.3.5. Spain Transcranial Magnetic Stimulation System Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Age Group

8. Asia Pacific Transcranial Magnetic Stimulation System Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Age Group
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Transcranial Magnetic Stimulation System Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Age Group
    • 8.3.2. India Transcranial Magnetic Stimulation System Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Age Group
    • 8.3.3. Japan Transcranial Magnetic Stimulation System Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Age Group
    • 8.3.4. South Korea Transcranial Magnetic Stimulation System Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Age Group
    • 8.3.5. Australia Transcranial Magnetic Stimulation System Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Age Group

9. Middle East & Africa Transcranial Magnetic Stimulation System Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Age Group
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Transcranial Magnetic Stimulation System Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Age Group
    • 9.3.2. UAE Transcranial Magnetic Stimulation System Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Age Group
    • 9.3.3. South Africa Transcranial Magnetic Stimulation System Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Age Group

10. South America Transcranial Magnetic Stimulation System Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Age Group
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Transcranial Magnetic Stimulation System Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Age Group
    • 10.3.2. Colombia Transcranial Magnetic Stimulation System Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Age Group
    • 10.3.3. Argentina Transcranial Magnetic Stimulation System Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Age Group

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Transcranial Magnetic Stimulation System Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. BrainsWay Ltd.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Magstim, Inc.
  • 15.3. Nexstim Oyj
  • 15.4. MagVenture A/S
  • 15.5. eNeura Inc.
  • 15.6. Koninklijke Philips N.V.
  • 15.7. Labtician Ophthalmics, Inc.
  • 15.8. Vision Care USA, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!